Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2013 by Westside Medical Associates of Los Angeles
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
David Gallegos, RN, Westside Medical Associates of Los Angeles
ClinicalTrials.gov Identifier:
NCT01804543
First received: August 3, 2012
Last updated: March 4, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)